PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2025 Financial Results
PTC Therapeutics (NASDAQ: PTCT) has scheduled its second quarter 2025 financial results conference call for Thursday, August 7, at 4:30 p.m. ET. The presentation will include financial results and a business update. Participants are advised to register in advance and dial in 15 minutes before the call to avoid delays.
The webcast will be accessible through PTC's investor relations website, with a replay available for 30 days after the presentation.
PTC Therapeutics (NASDAQ: PTCT) ha programmato la conference call per la presentazione dei risultati finanziari del secondo trimestre 2025 per giovedì 7 agosto, alle 16:30 ET. La presentazione includerà i risultati finanziari e un aggiornamento sull'attività aziendale. Si consiglia ai partecipanti di registrarsi in anticipo e di collegarsi 15 minuti prima dell'inizio per evitare ritardi.
La trasmissione in webcast sarà disponibile attraverso il sito web delle relazioni con gli investitori di PTC, con una replica accessibile per 30 giorni dopo la presentazione.
PTC Therapeutics (NASDAQ: PTCT) ha programado su llamada de conferencia para los resultados financieros del segundo trimestre de 2025 para el jueves 7 de agosto a las 4:30 p.m. ET. La presentación incluirá resultados financieros y una actualización del negocio. Se recomienda a los participantes registrarse con anticipación y conectarse 15 minutos antes de la llamada para evitar demoras.
La transmisión en vivo estará disponible a través del sitio web de relaciones con inversionistas de PTC, con una repetición accesible durante 30 días después de la presentación.
PTC Therapeutics (NASDAQ: PTCT)는 2025년 2분기 재무 결과 컨퍼런스 콜을 8월 7일 목요일 오후 4시 30분(동부시간)에 예정하고 있습니다. 발표에는 재무 결과와 사업 업데이트가 포함됩니다. 참가자는 지연을 방지하기 위해 사전에 등록하고 콜 시작 15분 전에 접속할 것을 권장합니다.
웹캐스트는 PTC의 투자자 관계 웹사이트를 통해 접속할 수 있으며, 발표 후 30일 동안 다시보기가 제공됩니다.
PTC Therapeutics (NASDAQ : PTCT) a programmé sa conférence téléphonique sur les résultats financiers du deuxième trimestre 2025 pour le jeudi 7 août à 16h30 ET. La présentation comprendra les résultats financiers ainsi qu'une mise à jour commerciale. Il est conseillé aux participants de s'inscrire à l'avance et de se connecter 15 minutes avant l'appel afin d'éviter tout retard.
Le webcast sera accessible via le site des relations investisseurs de PTC, avec une rediffusion disponible pendant 30 jours après la présentation.
PTC Therapeutics (NASDAQ: PTCT) hat seine Telefonkonferenz zu den Finanzergebnissen des zweiten Quartals 2025 für Donnerstag, den 7. August, um 16:30 Uhr ET angesetzt. Die Präsentation umfasst Finanzergebnisse und ein Geschäftsupdate. Teilnehmer werden gebeten, sich im Voraus zu registrieren und 15 Minuten vor Beginn der Konferenz einzuwählen, um Verzögerungen zu vermeiden.
Das Webcast ist über die Investor-Relations-Website von PTC zugänglich, mit einer Wiederholung, die 30 Tage nach der Präsentation verfügbar ist.
- None.
- None.
To access the call by phone, please click here to register and you will be provided with dial-in details. To avoid delays, we recommend participants dial in for the conference call 15 minutes prior to the start of the call. The webcast conference call can be accessed on the Investors section of the PTC website at https://ir.ptcbio.com/events-presentations. A replay of the call will be available approximately two hours after completion of the call and will be archived on the company's website for 30 days.
ABOUT PTC THERAPEUTICS, INC.
PTC is a global biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company's strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders. To learn more about PTC, please visit www.ptcbio.com and follow on Facebook, X, and LinkedIn.
For more information, please contact:
Investors:
Ellen Cavaleri
+1 (615) 618-8228
ecavaleri@ptcbio.com
Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-host-conference-call-to-discuss-second-quarter-2025-financial-results-302509838.html
SOURCE PTC Therapeutics, Inc.
FAQ
When is PTC Therapeutics (PTCT) reporting Q2 2025 earnings?
How can I access PTC Therapeutics Q2 2025 earnings call?
How long will PTC Therapeutics Q2 2025 earnings call replay be available?
What time should I dial in for PTC Therapeutics Q2 2025 earnings call?
